Date: Wednesday, January 17, 2017
Time: 10am PDT (1pm EDT)
Duration: 60 minutes
 
Register
 

How can stronger relationships be built between Sponsors and CROs?
How can the sharing of trial data improve trial outcomes?
What are the best ways to measure performance and conduct between Sponsor and CRO?

These are top challenges for Sponsors and CROs today.  In light of the ICH E6 (R2) guidelines, Sponsors and CROs are reviewing and assessing how well they work together.

This webinar will present a detailed look at the interactions and performance of Sponsor-CRO driven studies. Karen McCarthy Schau of Paragon, a leading consulting firm that helps health and life sciences companies become high-performing, compliant and digitally connected, joins Comprehend for this lively discussion.  The webinar will focus on three key strategies to address study oversight and support compliance with ICH E6 (R2):

  • Steps for assessing how aligned your organization is with R2 expectations for study oversight
  • Benefits of meeting R2 requirements with a risk-based oversight approach
  • How automation helps reduce the time and effort to improve performance, reduce risk and see across data
Join us for this informative session based on real-world Sponsor and CRO experiences.  Following the presentation, we’ll provide a short demonstration of how one Sponsor applied automation to manage these issues.
 

Featured Speakers:

IMG_0834.png

Julie Peacock, Clinical Intelligence Expert, Comprehend

Closely aligned with customers and the sales organization, Julie focuses on enabling prospects and customers on Comprehend’s Clinical Intelligence solutions. She manages go to market strategy, sales enablement, and product marketing.

Prior to Comprehend, Julie spent 18 years at Oracle Corporation in the enterprise application space where she managed strategy, field enablement and launch activities for a series of BtoB solutions. Julie holds a bachelor’s degree in Marketing from Auburn University.

Karen McCathy Schau.png

Karen McCarthy Schau, Associate Director, Paragon R&D Consulting

Karen McCarthy Schau is an Associate Director in Paragon’s R&D Consulting group, and joined Paragon in 2014. Karen has 19 years of diversified experience across functional areas with emphasis in Clinical Systems, and more than 10 years specializing in process reengineering and system implementation for a large global CRO.

Karen currently focuses on helping companies deploy solutions to streamline processes, improve productivity, and operational efficiency, and provides leadership and support for system implementations. She is a member of the MCC Metrics Consortium.